New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Body Fat Without Loss of Muscle Mass The natural GLP-1 activator is clinically shown to support fat loss, including visceral fat reduction, while preserving lean muscle AUCKLAND, New Zealand, July 23, 2026 --(BUSINESS WIRE)--Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, announces today the publication of a new clinical study in US medical journal, Obesity Pillars, demonstrating Calocurb's effectiveness in weight loss and muscle preservation
Protein status, micronutrients, inflammation load, sleep, blood sugar
Omega 3 c nhiu trong cc loi c nc lnh (c hi, c trch, c thu) qu c ch v cc loi ht nh chia, lanh cng du ca chng
We prioritize stability and purity in our formulations, ensuring that the glutathione remains in its "reduced" (active) state